Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10580898rdf:typepubmed:Citationlld:pubmed
pubmed-article:10580898lifeskim:mentionsumls-concept:C0302592lld:lifeskim
pubmed-article:10580898lifeskim:mentionsumls-concept:C0205101lld:lifeskim
pubmed-article:10580898lifeskim:mentionsumls-concept:C0006098lld:lifeskim
pubmed-article:10580898lifeskim:mentionsumls-concept:C0851346lld:lifeskim
pubmed-article:10580898lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:10580898lifeskim:mentionsumls-concept:C2347880lld:lifeskim
pubmed-article:10580898lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:10580898lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:10580898pubmed:issue5lld:pubmed
pubmed-article:10580898pubmed:dateCreated1999-12-13lld:pubmed
pubmed-article:10580898pubmed:abstractTextCervical cancer was treated with a combination of external beam and intracavitary radiation during a 10-year period at Wayne State University. Data were collected for 216 patients treated radically with external beam radiation (EBRT) and low-dose-rate brachytherapy for cervical cancer between 1980 and 1991 at Wayne State University. Patient distribution by stage was IB, 20.8%; IIA, 7.4%; IIB, 26.9%; IIIA, 1.8%; IIIB, 40.7%; and IVA, 2.3 %. Survival curves were constructed using Kaplan-Meier methods and differences between groups were tested for significance using the log-rank test. Multivariate analysis was done using the Cox proportional hazards model. With a median follow-up of 114 months, actuarial disease-free survival for all patients was 60% at 5 years and 55% at 10 years. Actuarial 5-year survival for Stage IB was 79%; for Stage II, 59%; and for Stage III, 53%. There were 14/216 (6%) of patients with severe late complications. On univariate analysis, race was found to be statistically significant, with Caucasian patients having better survival than African American (P = 0.03). The survival for patients treated in shorter overall times was significantly higher (P<0.001), especially with treatment completion in under 58 days. The stepwise Cox multivariate analysis provided the following significant results: race (African American vs. Caucasian; P = 0.04, RR = 1.6), Stage (II vs. I, P = 0.004, RR = 2.6), Stage (III vs. I; P = 0.004, RR = 2.5), and overall treatment time (P = 0.006, RR = 1.62). Rates of local control, survival, and complications among women treated with combined external beam and intracavitary radiation for cervix cancer were similar to those of prior retrospective studies.lld:pubmed
pubmed-article:10580898pubmed:languageenglld:pubmed
pubmed-article:10580898pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10580898pubmed:citationSubsetIMlld:pubmed
pubmed-article:10580898pubmed:statusMEDLINElld:pubmed
pubmed-article:10580898pubmed:issn1065-7541lld:pubmed
pubmed-article:10580898pubmed:authorpubmed-author:PorterAAlld:pubmed
pubmed-article:10580898pubmed:authorpubmed-author:DeppeGGlld:pubmed
pubmed-article:10580898pubmed:authorpubmed-author:OrtonCClld:pubmed
pubmed-article:10580898pubmed:authorpubmed-author:HartKKlld:pubmed
pubmed-article:10580898pubmed:authorpubmed-author:HanIIlld:pubmed
pubmed-article:10580898pubmed:authorpubmed-author:ShamsaFFlld:pubmed
pubmed-article:10580898pubmed:authorpubmed-author:ChubaP JPJlld:pubmed
pubmed-article:10580898pubmed:authorpubmed-author:StrowbridgeAAlld:pubmed
pubmed-article:10580898pubmed:issnTypePrintlld:pubmed
pubmed-article:10580898pubmed:volume7lld:pubmed
pubmed-article:10580898pubmed:ownerNLMlld:pubmed
pubmed-article:10580898pubmed:authorsCompleteYlld:pubmed
pubmed-article:10580898pubmed:pagination289-96lld:pubmed
pubmed-article:10580898pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:meshHeadingpubmed-meshheading:10580898...lld:pubmed
pubmed-article:10580898pubmed:year1999lld:pubmed
pubmed-article:10580898pubmed:articleTitleCombined low-dose-rate brachytherapy and external beam radiation for cervical cancer: experience over ten years.lld:pubmed
pubmed-article:10580898pubmed:affiliationDepartment of Radiation Oncology, Barbara Ann Karmanos Cancer Center, Detroit, Michigan, USA. hanihn@karmanos.orglld:pubmed
pubmed-article:10580898pubmed:publicationTypeJournal Articlelld:pubmed